ST14 Antikörper (N-Term)
Kurzübersicht für ST14 Antikörper (N-Term) (ABIN615862)
Target
Alle ST14 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- N-Term
-
Spezifität
- This antibody reacts to the N-term of Suppression Of Tumorigenicity 14 (colon Carcinoma, Matriptase, Epithin) (ST14).
-
Aufreinigung
- Immunoaffinity Chromatography
-
Immunogen
- ST14 antibody was raised against synthetic peptide - KLH conjugated Genename: ST14
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Konzentration
- 1,0 mg/mL
-
Buffer
- PBS (without Mg2+, Ca2+), pH 7.4 containing 150 mM sodium chloride, 0.02 % sodium azide as preservative and 50 % glycerol as stabilizer
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freezing and thawing.
-
Lagerung
- -20 °C
-
-
- ST14 (Suppression of Tumorigenicity 14 (ST14))
-
Andere Bezeichnung
- ST14 / Matriptase
-
Hintergrund
- Synonyms: Membrane-type serine protease 1, PRSS14, Prostamin, SNC19, Serine protease 14, Serine protease TADG-15, Suppressor of tumorigenicity 14 protein, T-SP1, TADG15, Tumor-associated differentially-expressed gene 15 protein
-
Gen-ID
- 6768
-
NCBI Accession
- NP_068813
-
UniProt
- Q9Y5Y6
Target
-